- Home
- CPHI vs BMRA Comparison
CPHI vs BMRA Comparison
Compare CPHI & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPHI
- BMRA
- Stock Information
- Founded
- CPHI N/A
- BMRA 1971
- Country
- CPHI China
- BMRA United States
- Employees
- CPHI N/A
- BMRA N/A
- Industry
- CPHI Biotechnology: Pharmaceutical Preparations
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CPHI Health Care
- BMRA Health Care
- Exchange
- CPHI Nasdaq
- BMRA Nasdaq
- Market Cap
- CPHI 7.3M
- BMRA 8.1M
- IPO Year
- CPHI N/A
- BMRA N/A
- Fundamental
- Price
- CPHI $1.83
- BMRA $3.09
- Analyst Decision
- CPHI
- BMRA
- Analyst Count
- CPHI 0
- BMRA 0
- Target Price
- CPHI N/A
- BMRA N/A
- AVG Volume (30 Days)
- CPHI 152.1K
- BMRA 26.1K
- Earning Date
- CPHI 08-13-2025
- BMRA 04-14-2025
- Dividend Yield
- CPHI N/A
- BMRA N/A
- EPS Growth
- CPHI N/A
- BMRA N/A
- EPS
- CPHI N/A
- BMRA N/A
- Revenue
- CPHI $4,295,377.00
- BMRA $5,678,000.00
- Revenue This Year
- CPHI N/A
- BMRA N/A
- Revenue Next Year
- CPHI N/A
- BMRA N/A
- P/E Ratio
- CPHI N/A
- BMRA N/A
- Revenue Growth
- CPHI N/A
- BMRA 5.01
- 52 Week Low
- CPHI $1.20
- BMRA $1.93
- 52 Week High
- CPHI $3.35
- BMRA $10.16
- Technical
- Relative Strength Index (RSI)
- CPHI 52.11
- BMRA 45.39
- Support Level
- CPHI $1.55
- BMRA $3.03
- Resistance Level
- CPHI $1.91
- BMRA $3.44
- Average True Range (ATR)
- CPHI 0.18
- BMRA 0.19
- MACD
- CPHI 0.02
- BMRA 0.01
- Stochastic Oscillator
- CPHI 61.38
- BMRA 43.24
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.